Recce raises A$4M as it advances anti-infective trials and commercial licensing plans; another $4M to come in SPP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results